MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with C

Cenobamate

Cenobamate 12.5mg tablets

No stability information

Stability notes for Cenobamate 12.5mg tablets

There are no stability notes for this medicine.

Supplier

Ontozry 12.5mg tablets (Angelini Pharma UK-I Ltd)

Cenobamate 12.5mg tablets and Cenobamate 25mg tablets

No stability information

Stability notes for Cenobamate 12.5mg tablets and Cenobamate 25mg tablets

There are no stability notes for this medicine.

Supplier

Ontozry 12.5mg/25mg tablets treatment initiation pack (Angelini Pharma UK-I Ltd)

Cenobamate 25mg tablets

No stability information

Stability notes for Cenobamate 25mg tablets

There are no stability notes for this medicine.

Supplier

Ontozry 25mg tablets (Angelini Pharma UK-I Ltd)

Cenobamate 50mg tablets

No stability information

Stability notes for Cenobamate 50mg tablets

There are no stability notes for this medicine.

Suppliers

Ontozry 50mg tablets (Angelini Pharma UK-I Ltd)
Ontozry 50mg tablets (Pharmaram Ltd)
Ontozry 50mg tablets (Pilsco Ltd)

Cenobamate 100mg tablets

No stability information

Stability notes for Cenobamate 100mg tablets

There are no stability notes for this medicine.

Suppliers

Ontozry 100mg tablets (Angelini Pharma UK-I Ltd)
Ontozry 100mg tablets (Pharmaram Ltd)

Cenobamate 150mg tablets

No stability information

Stability notes for Cenobamate 150mg tablets

There are no stability notes for this medicine.

Suppliers

Ontozry 150mg tablets (Angelini Pharma UK-I Ltd)
Ontozry 150mg tablets (Pharmaram Ltd)

Cenobamate 200mg tablets

No stability information

Stability notes for Cenobamate 200mg tablets

There are no stability notes for this medicine.

Suppliers

Ontozry 200mg tablets (Angelini Pharma UK-I Ltd)
Ontozry 200mg tablets (Pharmaram Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.